1. Home
  2. MRKR vs PSHG Comparison

MRKR vs PSHG Comparison

Compare MRKR & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.61

Market Cap

22.5M

Sector

Health Care

ML Signal

HOLD

Logo Performance Shipping Inc.

PSHG

Performance Shipping Inc.

HOLD

Current Price

$1.68

Market Cap

20.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRKR
PSHG
Founded
1999
2010
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
22.5M
20.9M
IPO Year
2010
2010

Fundamental Metrics

Financial Performance
Metric
MRKR
PSHG
Price
$1.61
$1.68
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
64.6K
45.6K
Earning Date
05-14-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
33.61
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$49.57
Revenue Next Year
$936.27
$2.73
P/E Ratio
N/A
$1.59
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$1.61
52 Week High
$4.07
$2.58

Technical Indicators

Market Signals
Indicator
MRKR
PSHG
Relative Strength Index (RSI) 66.31 41.20
Support Level $1.35 $1.62
Resistance Level $1.69 $1.99
Average True Range (ATR) 0.08 0.07
MACD 0.03 -0.00
Stochastic Oscillator 78.51 20.93

Price Performance

Historical Comparison
MRKR
PSHG

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

About PSHG Performance Shipping Inc.

Performance Shipping Inc is a shipping company. The company is a provider of shipping transportation services through the ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying container vessels and cargo along various shipping routes. It owns and operates Aframax and Suezmax tanker vessels.

Share on Social Networks: